The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Confirmation Tests
Acidic, Neutral and Basic Drugs
- TX-PM 4.1.1 Qualitative Confirmation of Acidic, Neutral and Basic Drugs in Urine
- TX-PM 4.1.2 Quantitative ANB
- TX-PM 4.1.3 Confirmation of Opiates
- TX-PM 4.1.4 Qualitative Confirmation of Acidic, Neutral and Basic Drugs in Other Biological Matrices
- TX-PM 4.1.5 LC-MS/MS - Drugs of Abuse (LCDOA) Confirmatory Analysis in Blood
Benzodiazepines
- TX-PM 4.2.1 Benzodiazepine Confirmation and Quantification in Blood
- TX-PM 4.2.2 Qualitative Confirmation of Benzodiazepines in Blood and Urine
Cannabinoids
- TX-PM 4.3.1 Qualitative Confirmation of Marihuana Metabolite in Urine
- TX-PM 4.3.2 Quantitative Confirmation of Cannabinoids in Blood
GHB
- TX-PM 4.4.1 Confirmation and Quantification of GHB in Blood
- TX-PM 4.4.2 Confirmation and Quantification of GHB in Urine
Other Analyses
Quality Assurance/Quality Control
- TX-PM 5.1 Controls
- TX-PM 5.2 Pipettes, Pipettor-Dilutors, Balances, pH Meter and Volumetric Glassware
- TX-PM 5.3 Method Validation, Instrument Validation, Studies and Experiments
- TX-PM 5.4 Instrument Repair Procedures
- TX-PM 5.5 Refrigerator and Freezer Temperature Monitoring
- TX-PM 5.6 Reference Standards and Materials
- TX-PM 5.7 Administrative and Technical Reviews
- TX-PM 5.8 Outsourcing Casework
- TX-PM 5.9 Processing Method Review
- TX-PM 5.10 Deviation from Test Methods
- TX-PM 5.11 Release of Casework
- TX-PM 5.12 Sequence List and Vial Review
- TX-PM 5.13 Administrative Errors on Casework
- TX-PM 5.14 Proficiency Test Evaluation Criteria
- TX-PM 5.15 Instrument Operating Parameters
- TX-PM 5.16 Identifying Evidence Prior to Analysis
- TX-PM 5.17 Testimony
- TX-PM 5.18 Suitability of Evidence
- TX-PM 5.19 Metrological Traceability of Pipettes